News & Articles

The real-time RT-PCR assay can simultaneously detect and differentiate 8 target genes, the first and only test to do so in the world

Take a look back at the technologies, innovations and clinical advances that hit the headlines over the past 12 months

Preliminary results show 92% sensitivity and 100% specificity, compared with RT-PCR

Elecsys Anti-SARS-CoV-2 S test specifically detects antibodies against the SARS- CoV-2 spike protein

Watch this on-demand webinar to find out how targeting B-cell maturation antigen and GPRC5D simultaneously could help to prevent tumor cell escape

The research helps shed light on genes responsible for a shield-like capsule that could help protect some bacteria from our immune system, making them deadly

Explore ways to improve time to result in critical pathways such as sepsis

HALIX to provide large-scale GMP manufacture of AZD1222

In a 17-4 vote, the FDA vaccine advisory committee recommended that Pfizer/BioNTech’s COVID-19 vaccine should be distributed to the U.S.

Parties to collaborate on development, commercialization, and supply of the Orgenesis therapies pipeline

Here’s what you should know when choosing the best bottles for your cell culture experiment

The kit is ideally suited to NGS library preparation from a low input, patient-derived sample types, such as nasal swabs

Join us on Thursday, December 10, to discover how to rapidly diagnose antimicrobial resistance for appropriate therapy

Watch this on-demand webinar to learn how COVID immune responses can be assessed using a novel microfluidic in-solution immunoassay platform

Researchers recommend that targeted nutrition should be urgently explored as a counter-measure to mitochondrial damage

Designed to enrich pathologists' skills in biomarker interpretation and scoring techniques

The assay is developed for use in detection, characterisation, and monitoring of the SARS-CoV-2 virus

Access SARS-CoV-2 IgG II test is a semi-quantitative assay that measures patient’s relative level of antibodies in response to a previous SARS-CoV-2 infection

Two different dosing regimens demonstrated efficacy with one showing a better profile

The collaboration aims to secure manufacturing and testing capacity in the next phase of the pandemic

Observations of rapid recovery on chest x-rays noted and no drug-related Serious Adverse Events reported

The new lots further enhance Lonza’s renowned human primary cell offerings as it looks to meet growing market demand for deeper cell characterization

Test adds to QIAGEN’s growing portfolio of PCR testing solutions for COVID-19 testing

QIAreach SARS-CoV-2 Antigen Test is an important step towards decentralized mass screening by processing samples in 2–15 minutes

Phase 3 part of clinical trial to enrol over 30,000 volunteers worldwide